Compare Crispr Therapeutics AG (CRSP) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Zoom Video Communications, Inc. — how do they compare? Crispr Therapeutics AG trades at $53.39 (market cap $4.88B), while Zoom Video Communications, Inc. trades at $97.74 (market cap $27.62B). The key difference: Zoom Video Communications, Inc. is far larger — about 5.7× Crispr Therapeutics AG's market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Zoom Video Communications, Inc. for 92 Days on average.
| CRSP | ZM | |
|---|---|---|
Market Cap | $4.88B | $27.62B |
Volume | 2,861,747 | 3,913,188 |
Sector | Health | Technology |
52-Week High | $73.97 | $111.88 |
52-Week Low | $44.34 | $72.72 |
Typical Hold Time | 77 Days | 92 Days |
Enterprise Value | $3.30B | $20.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $50.44, down 3.65% amid bearish technical signals. The company shows negative profitability with -$581.60M net income and -4,101.26% net margin for 2025, though Q2 2026 EPS beat expectations. Positive analyst sentiment persists with 57.9% buy ratings and $67.83 consensus target. Recent clinical data presentations and CASGEVY commercial progress provide catalysts.
The stock faces fundamental challenges with persistent losses and negative cash flow from operations, but maintains Wall Street support for its gene-editing pipeline. Key risks include clinical trial outcomes and cash burn, while potential upside hinges on successful drug commercialization and upcoming data readouts through 2026.
Zoom Communications (ZM) trades at $94.67, showing minimal daily movement (-0.11%). The stock maintains a bullish technical outlook with strong moving average signals, though oscillators indicate neutral momentum. Fundamentally, ZM demonstrates robust profitability with 77.3% gross margins and 65.19% net income margin, supported by recent earnings beats. The company continues to innovate with AI-powered revenue solutions and maintains significant institutional interest.
With a consensus price target of $118.08 offering 25% upside potential, ZM presents growth opportunities driven by AI integration and strong financial metrics. However, risks include competitive pressures in the communication software space and reliance on international sales growth. The mixed analyst sentiment (38.78% buy vs 55.1% hold) suggests cautious optimism amid solid fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
